IL-8 treatment induced p-p38 MAPK and p-ERK expression and increased the expressions of p-IκB-α and nuclear factor (NF)-κB, both markers for inflammatory response, through modulating the MAPK and NF-κB pathways in HNSCC cells [106]. Here, CXCL8 is linked to head and neck squamous cell carcinoma.